According to Reuters, Activist investor Elliott pushes Alexion Pharma to sell itself

POTENTIAL DEAL DETAILS

Stock Alexion Pharmaceuticals, Inc. Symbol ALXN
Date Announced 05/12/2020 Source Reuters
Type Company Seeking Strategic Alternatives
Date of Confirmation: 12/12/2020 Price at Confirmation: $120.98
Potential Profit: 19.02% Annualized Profit: 32.43%

Hedge fund Elliott Management on Tuesday publicly called on Alexion Pharmaceuticals Inc (ALXN) to sell itself, arguing that management’s steps, including recent plans to acquire a smaller company, were leading in the wrong direction.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.

Leave A Comment

You must be logged in to post a comment.